Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1155/2015/120207 http://scihub22266oqcxt.onion/10.1155/2015/120207 C4644845!4644845!26609306     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Gastroenterol+Res+Pract 2015 ; 2015 (ä): ä Nephropedia Template TP {{tp|p=26609306|t=2015. Current State of Vascular Resections in Pancreatic Cancer Surgery |pdf=|usr=}}{{26609306}} gab.com Text Current State of Vascular Resections in Pancreatic Cancer Surgery JO: Gastroenterol Res Pract http://www.kidney.de/pget.php?&tw=1&pmid=26609306 #FOAvip Pancreatic cancer (PDAC) is the fourth leading cause of cancer-related mortality in the Western world and, even in 2014, a therapeutic challenge. The only chance for long-term survival is radical surgical resection followed by adjuvant chemotherapy which can be performed in about 20% of all PDAC patients by the time of diagnosis. As pancreatic surgery has significantly changed during the past years, extended operations, including vascular resections, have become more frequently performed in specialized centres and the border of resectability has been pushed forward to achieve a potentially curative approach in the respective patients in combination with neoadjuvant and adjuvant treatment strategies. In contrast to adjuvant treatment which has to be regarded as a cornerstone to achieve long-term survival after resection, neoadjuvant treatment strategies for locally advanced findings are currently under debate. This overview summarizes the possibilities and evidence of vascular, namely, venous and arterial, resections in PDAC surgery. Twit Text FOAVip Current State of Vascular Resections in Pancreatic Cancer Surgery ????Gastroenterol Res Pract http://www.kidney.de/pget.php?&tw=1&pmid=26609306 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26609306 #FOAvip English Wikipedia <ref>{{Cite pmid|26609306}}</ref> Current State of Vascular Resections in Pancreatic Cancer Surgery #MMPMID26609306 Hackert T; Schneider L; Büchler MW Gastroenterol Res Pract 2015[]; 2015 (ä): ä PMID26609306show ga Pancreatic cancer (PDAC) is the fourth leading cause of cancer-related mortality in the Western world and, even in 2014, a therapeutic challenge. The only chance for long-term survival is radical surgical resection followed by adjuvant chemotherapy which can be performed in about 20% of all PDAC patients by the time of diagnosis. As pancreatic surgery has significantly changed during the past years, extended operations, including vascular resections, have become more frequently performed in specialized centres and the border of resectability has been pushed forward to achieve a potentially curative approach in the respective patients in combination with neoadjuvant and adjuvant treatment strategies. In contrast to adjuvant treatment which has to be regarded as a cornerstone to achieve long-term survival after resection, neoadjuvant treatment strategies for locally advanced findings are currently under debate. This overview summarizes the possibilities and evidence of vascular, namely, venous and arterial, resections in PDAC surgery. äCurrent State of Vascular Resections in Pancreatic Cancer Surgery (epmc).pdf DeepDyve Pubget Overpricing